key: cord-1022217-pymwwyez
authors: Renieris, Georgios; Katrini, Konstantina; Giamarellos-Bourboulis, Evangelos J.
title: Reply to Radermacher et al. on “Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus”
date: 2020-06-23
journal: Shock
DOI: 10.1097/shk.0000000000001603
sha: 845929463fb6f130b015fe1efd0227558f93a8fc
doc_id: 1022217
cord_uid: pymwwyez

nan

To the Editor: We read with great interest the comments addressed by Radermacher et al. (1) on our publication regarding the importance of hydrogen sulfide (H 2 S) for the prognosis and outcome of severe infection caused by the novel SARS-CoV-2 (also known as Covid-19) (2) . Although serum H 2 S levels as high as 249 mM and 580 mM have been demonstrated in patients with septic shock (3) and severe asthma (4), we agree that the elevated serum H 2 S is an intriguing finding. We tried to deliver some answers that are based on: the performance of the used assay in healthy volunteers and in patients with other types of severe lung infection; and the reproducibility of the data by using another assay.

We measured levels of H 2 S in 17 healthy volunteers and in 60 patients with ventilator-associated pneumonia (VAP). VAP was diagnosed according to standard definitions (5) and all patients had microbiological confirmation with one Gram-negative pathogen isolated in counts greater than 10 5 colony-forming units/mL from the bronchoalveolar lavage by the culture technique already described (6) . Isolated pathogens were Acinetobacter baumannii (n ¼ 23), Pseudomonas aeruginosa (n ¼ 19), and Klebsiella pneumoniae (n ¼ 18). Blood samples were collected within the first 24 h from diagnosis of VAP and H 2 S was measured by the monobromobimane derivatization assay followed by reverse phase HPLC separation (2) . Results clearly showed that survivors from Covid-19 had H 2 S levels significantly greater than healthy population and patients with VAP (Fig. 1) . This elaborates the hypothesis that it is not the assay that leads to false-positive increased H 2 S levels, but that H 2 S increase may well be an intrinsic characteristic of Covid-19 described for the first time herein. H 2 S of healthy was also within reported ranges (7) .

To strengthen the finding of increased H 2 S in Covid-19 survivors, H 2 S was measured in the same samples by a photometric methylene blue assay (8) . Despite the lack of specificity of this assay leading to higher measurable levels, the interpretation of the findings was the same (Fig. 2) .

We feel that Covid-19 is a new territory of research where modulation of H 2 S plays a major role and we wish to thank Rademacher et al. (1) for paving us the way to strengthen our data.

Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 coronavirus. Shock; 2020

Sputum hydrogen sulfide as a novel biomarker of obstructive neutrophilic asthma

Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse

The International Sepsis Forum Consensus Conference on definitions of infection in the intensive care unit: critical care medicine

Point-counterpoint: quantitative cultures of bronchoscopically obtained specimens should be performed for optimal management of ventilator-associated

Rapid measurement of hydrogen sulphide in human blood plasma using a microfluidic method

The effect of CSE gene deletion in caerulein-induced acute pancreatitis in the mouse

Hydrogen sulfide (H 2 S) levels in serum of (A) healthy volunteers; (B) patients with ventilator associated pneumonia (VAP) by P aeruginosa

C) patients with pneumonia by the SARS-CoV-2 coronavirus on day 1 after hospital admission measured by monobromobimane derivatization assay followed by reverse phase HPLC separation. Comparison by the Mann-Whitney U test

Hydrogen sulfide (H 2 S) levels in serum of (A) healthy volunteers; (B) survivors; and (C) non-survivors of pneumonia by the SARS-CoV-2 coronavirus on day 1 after hospital admission measured by a photometric methylene blue assay. Comparison by the Mann-Whitney U test